This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

CARISMA : Cardiac Arrhythmias and Risk Stratification After MyoCardial Infarction

This study has been completed.
Information provided by:
Medtronic Bakken Research Center Identifier:
First received: September 2, 2005
Last updated: November 4, 2015
Last verified: January 2014
The purpose of this study is to assess the incidence of tachy- and bradyarrhythmic episodes in patients with acute myocardial infarction with depressed ventricular function and to determine the predictive value of several invasive and non-invasive risk markers for life-threatening arrhythmia

Acute Myocardial Infarction

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Incidence and Prediction of Life-threatening Cardiac Arrhythmias in Patients With Depressed Left Ventricular Function After Acute Myocardial Infarction

Resource links provided by NLM:

Further study details as provided by Medtronic Bakken Research Center:

Primary Outcome Measures:
  • ECG-documented Ventricular Fibrillation or Symptomatic Sustained Ventricular Tachycardia (VT) [ Time Frame: 2 year ]
    ECG-documented ventricular fibrillation or symptomatic sustained ventricular tachycardia (VT)

Enrollment: 312
Study Start Date: August 2001
Study Completion Date: May 2007
Primary Completion Date: May 2007 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Acute myocardial infarction (< 21 days)
  • Ejection fraction <= 40 % or wall motion index <= 1.3

Exclusion Criteria:

  • Implantable loop recorder can't be implanted within 3 weeks after MI
  • NYHA class IV
  • Planned or previous ICD implantation
  • Planned CABG
  • Severe valvular disease
  • Pregnancy
  • Life expectancy < 1 year for non-cardiac cause
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00145119

Medtronic Bakken Research Center B.V.
Maastricht, Netherlands
Sponsors and Collaborators
Medtronic Bakken Research Center
Principal Investigator: H. Huikuri, Prof. Oulu University Central Hospital, Finland
Principal Investigator: P. E. Bloch-Thomsen, Dr. Gentofte University Hospital, Denmark
  More Information

Publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT00145119     History of Changes
Other Study ID Numbers: Medtronic_BRC_CRM_001
Study First Received: September 2, 2005
Results First Received: December 2, 2013
Last Updated: November 4, 2015

Keywords provided by Medtronic Bakken Research Center:
Acute myocardial infarction
Cardiac arrhythmias
Left ventricular dysfunction
Implantable loop recorder
Risk stratifiers

Additional relevant MeSH terms:
Myocardial Infarction
Arrhythmias, Cardiac
Pathologic Processes
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases processed this record on September 21, 2017